EX-FILING FEES 4 ex107.htm

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

Enveric Biosciences, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Securities to Be Registered and Carry Forward Securities

 

   Security
Type
  Security
Class Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
to
Be
Registered (1)
   Proposed
Maximum
Offering
Price Per
Share (2)
   Proposed
Maximum
Aggregate
Offering
Price (2)
   Fee Rate   Amount of
Registration
Fee (2)
 
Securities to Be Registered
Fees to Be Paid  Equity  Shares of Common Stock, $0.01 par value per share  Other   4,900,000   $ 0.50    $ 2,450,000     0.00014760   $ 361.62  
   Total Offering Amounts        $ 2,450,000         $ 361.62  
   Total Fees Previously Paid                    
   Total Fee Offsets                    
   Net Fee Due                  $ 361.62  

 

(1) Represents shares of common stock that are issuable at the option of the registrant pursuant to a purchase agreement with the selling stockholder. The shares will be offered for resale by the selling stockholder. Pursuant to Rule 416(a), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

 

(2) In accordance with Rule 457(c), based on the average of the high ($0.52) and low ($0.48) prices of the Common Stock on the Nasdaq Capital Market on August 30, 2024.

 

Table 3: Combined Prospectuses

 

Security

Type

  Security Class Title  

Amount of Securities

 Previously Registered(1)

 

 Maximum Aggregate Offering 

Price of Securities Previously

Registered

   

 Form 

Type

  File Number  

 Initial Effective 

Date

                             
Equity   Equity   1,279,880 (3)   $2,431,772     S-1   333-275380   12/5/2023

 

(3) No registration fee is payable in connection with the aggregate of 1,279,880 shares of Common Stock previously registered under the Registration Statement on Form S-1 filed with the SEC on November 8, 2023 and amended on December 1, 2023, which was declared effective by the SEC on December 5, 2023 (SEC File No. 333-275380) (the “Prior Registration Statement”) because such securities are being transferred from the Prior Registration pursuant to Rule 429(b) under the Securities Act. See “Rule 429 Statement” in this registration statement.